Wintrust Investments’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $597K | Buy |
1,937
+900
| +87% | +$277K | 0.53% | 38 |
|
|
2024
Q3 | $220K | Sell |
1,037
-20,333
| -95% | -$4.31M | 0.16% | 120 |
|
|
2024
Q2 | $5.99M | Buy |
21,370
+2,100
| +11% | +$588K | 0.49% | 37 |
|
|
2024
Q1 | $5.15M | Sell |
19,270
-1,250
| -6% | -$334K | 0.45% | 45 |
|
|
2023
Q4 | $4.75M | Sell |
20,520
-5,365
| -21% | -$1.24M | 0.46% | 40 |
|
|
2023
Q3 | $3.78M | Buy |
25,885
+17,500
| +209% | +$2.56M | 0.4% | 53 |
|
|
2023
Q2 | $1.94M | Buy |
8,385
+2,035
| +32% | +$470K | 0.19% | 104 |
|
|
2023
Q1 | $1.54M | Buy |
6,350
+600
| +10% | +$145K | 0.2% | 100 |
|
|
2022
Q4 | $1.67M | Buy |
+5,750
| New | +$1.67M | 0.22% | 92 |
|